Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies

被引:0
|
作者
Cho, Sung-Yeon [1 ,2 ,3 ]
Lee, Dong-Gun [1 ,2 ,3 ]
Kim, Won-Bok [2 ]
Chun, Hye-Sun [2 ]
Park, Chulmin [2 ]
Myong, Jun-Pyo [4 ]
Park, Yeon-Joon [5 ]
Choi, Jae-Ki [1 ,2 ]
Lee, Hyo-Jin [1 ,2 ]
Kim, Si-Hyun [1 ,2 ]
Park, Sun Hee [1 ,2 ]
Choi, Su-Mi [1 ,2 ]
Choi, Jung-Hyun [1 ,2 ]
Yoo, Jin-Hong [1 ,2 ]
机构
[1] Catholic Univ Korea, Div Infect Dis, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Vaccine Bio Res Inst, Seoul, South Korea
[3] Catholic Hematol Hosp, Seoul, South Korea
[4] Catholic Univ Korea, Occupat & Environm Med, Coll Med, Seoul, South Korea
[5] Catholic Univ Korea, Dept Lab Med, Coll Med, Seoul, South Korea
关键词
Aspergillus; azoles; drug resistance mechanisms; environmental microbiology; hematologic diseases; IN-VITRO SUSCEPTIBILITY; AZOLE RESISTANCE; INVASIVE ASPERGILLOSIS; AMPHOTERICIN-B; FUMIGATUS; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE; PROPHYLAXIS; FLUCONAZOLE;
D O I
10.1128/JCM.02023-18
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Global data on the epidemiology and susceptibility of Aspergillus are crucial in the management of invasive aspergillosis. Here, we aimed to determine the characteristics of clinical and environmental Aspergillus isolates, focusing mainly on hematologic malignancy patients. We prospectively collected all consecutive cases and clinical isolates of culture-positive proven/probable invasive aspergillosis patients from January 2016 to April 2018 and sampled the air inside and outside the hospital. Cryptic species-level identification of Aspergillus, antifungal susceptibilities, and cyp51 gene sequencing were performed, and clinical data were analyzed. This study was conducted as part of the Catholic Hematology Hospital Fungi Epidemiology (CAFE) study. A total of 207 proven/probable invasive aspergillosis and 102 clinical and 129 environmental Aspergillus isolates were included in this analysis. The incidence of proven/probable invasive aspergillosis was 1.3 cases/1,000 patient-days during the study period. Cryptic Aspergillus species accounted for 33.8%, with no differences in proportions between the clinical and environmental isolates. Section Nigri presented a high proportion (70.5%) of cryptic species, mainly from A. tubingensis and A. awamori: the former being dominant in environmental samples, and the latter being more common in clinical isolates (P < 0.001). Of 91 A. fumigatus isolates, azole-resistant A. fumigatus was found in 5.3% of all A. fumigatus isolates. Three isolates presented the TR 34 /L98H mutation of the cyp51A gene. Patients with invasive aspergillosis caused by azole-resistant A. fumigatus showed 100% all-cause mortality at 100 days. This study demonstrates the significant portion of cryptic Aspergillus species and clinical implications of azole resistance and underscores the comparison between clinical and environmental isolates.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients
    Pfaller, M
    Zhang, J
    Messer, S
    Tumberland, M
    Mbidde, E
    Jessup, C
    Ghannoum, M
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (03) : 191 - 199
  • [42] In vitro antifungal susceptibility of Aspergillus terreus species complex clinical isolates: a multicentre study in eight university hospitals
    Imbert, S.
    Normand, A. C.
    Ranque, S.
    Costa, J. M.
    Hennequin, C.
    Accoceberry, I.
    Bonnal, C.
    Houze, S.
    Fekkar, A.
    Bourgeois, N.
    Piarroux, R.
    Botterel, F.
    Dannaoui, E.
    [J]. MYCOSES, 2017, 60 : 67 - 68
  • [43] Comparison of the VITEK 2 antifungal susceptibility system with Etest using clinical isolates of Candida species
    Alfouzan, Wadha
    Al-Enezi, Tahani
    AlRoomi, Ebteehal
    Sandhya, Vayalil
    Chandy, Rachel
    Khan, Zia Uddin
    [J]. REVISTA IBEROAMERICANA DE MICOLOGIA, 2017, 34 (03): : 171 - 174
  • [44] Species distribution and antifungal susceptibility profile of Candida isolates from bloodstream infections in Lima, Peru
    Bustamante, B.
    Martins, M. A.
    Bonfietti, L. X.
    Szeszs, M. W.
    Jacobs, J.
    Garcia, C.
    Melhem, M. S. C.
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 855 - 860
  • [45] Azole susceptibility in clinical and environmental isolates of Aspergillus fumigatus from eastern Hokkaido, Japan
    Toyotome, Takahito
    Fujiwara, Takayuki
    Kida, Hideyuki
    Matsumoto, Munehiro
    Wada, Terumi
    Komatsu, Ryoichi
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (9-10) : 648 - 650
  • [46] Molecular epidemiology and antifungal susceptibilities of Aspergillus species isolated from patients with invasive aspergillosis
    Sariguzel, Fatma Mutlu
    Koc, Ayse Nedret
    Sagiroglu, Pinar
    Atalay, Mustafa Altay
    Borlu, Arda
    Canoz, Ozlem
    Dinc, Bedia
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (01): : 44 - 50
  • [47] Genetic relatedness and antifungal susceptibility profile of Candida albicans isolates from fungaemia patients
    Costa-de-Oliveira, Sofia
    Sousa, Ines
    Correia, Alexandra
    Sampaio, Paula
    Pais, Celia
    Rodrigues, Acacio Goncalves
    Pina-Vaz, Cidalia
    [J]. MEDICAL MYCOLOGY, 2011, 49 (03) : 248 - 252
  • [48] Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil
    Souza, L. K. H.
    Souza Junior, A. H.
    Costa, C. R.
    Faganello, J.
    Vainstein, M. H.
    Chagas, A. L. B.
    Souza, A. C. M.
    Silva, M. R. R.
    [J]. MYCOSES, 2010, 53 (01) : 62 - 67
  • [49] The Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Aspergillus Section Flavi from Three French Hospitals
    Djenontin, Elie
    Costa, Jean-Marc
    Mousavi, Bita
    Nguyen, Lin Do Ngoc
    Guillot, Jacques
    Delhaes, Laurence
    Botterel, Francoise
    Dannaoui, Eric
    [J]. MICROORGANISMS, 2023, 11 (10)
  • [50] In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs
    Shivaprakash, M. R.
    Geertsen, Erik
    Chakrabarti, Arunaloke
    Mouton, Johan W.
    Meis, Jacques F.
    [J]. MYCOSES, 2011, 54 (05) : E583 - E589